Severe hemosiderosis post allogenic bone marrow transplantation

Hematological Oncology
P MahendraR E Marcus

Abstract

Abnormal liver function persisting late after allogeneic BMT is usually attributed to chronic GvHD, viral hepatitis or drug toxicity. We describe a patient who had negative hepatitis serology, was on no hepatotoxic medication, had no evidence of GvHD but had abnormal liver function 15 months post MBT. She was diagnosed as having grade IV hemosiderosis of the liver. Her total red cell support had only been 52 units. We therefore postulate that in a proportion of patients receiving allogeneic BMT impaired intestinal iron absorption may be an important cause of hemosiderosis.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú
Martín Tagle ArróspideE Luna Campodónico
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Ying ShanHerbert L Bonkovsky
Clinics in Liver Disease
Sripriya Balasubramanian, Kris V Kowdley
© 2021 Meta ULC. All rights reserved